Can a drug that calms inflammation ease chronic sinusitis?

NCT ID NCT04678856

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether dupilumab, an injectable drug that blocks certain inflammatory signals, can reduce sinus swelling and improve symptoms like loss of smell and runny nose in adults with chronic sinusitis who do not have nasal polyps. Participants receive either dupilumab or a placebo for 24 weeks. The study measures changes in CT scans and symptom scores to see if the drug offers relief for this hard-to-treat condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an injectable drug called dupilumab
What this could lead to
If it works, this could offer a new treatment option for people with chronic sinusitis who don't have nasal polyps and haven't been helped by standard therapies.
What could go wrong
This is a small, early-phase trial, so results may not apply to everyone. Dupilumab can cause injection-site reactions and allergic reactions, and it may not improve symptoms for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alamo ENT Associates Site Number : 8400021

    San Antonio, Texas, 78258, United States

  • Bensch Clinical Research LLC Site Number : 8400015

    Stockton, California, 95207, United States

  • Colorado Allergy and Asthma Centers, PC Site Number : 8400003

    Denver, Colorado, 80230, United States

  • Eastern Virginia Medical School (EVMS) Medical Group - Otola Site Number : 8400009

    Norfolk, Virginia, 23507, United States

  • Essential Medical Research, LLC Site Number : 8400014

    Tulsa, Oklahoma, 74137, United States

  • Investigational Site Number : 0320001

    Ciudad Autonoma Buenos Aires, C1425BEN, Argentina

  • Investigational Site Number : 0320002

    Buenos Aires, C1121ABE, Argentina

  • Investigational Site Number : 0320003

    Ciudad Autonoma Buenos Aires, C1414AIF, Argentina

  • Investigational Site Number : 0560001

    Leuven, 3000, Belgium

  • Investigational Site Number : 0560002

    Ghent, 9000, Belgium

  • Investigational Site Number : 1240001

    Montreal, Quebec, H2X 3E4, Canada

  • Investigational Site Number : 1240002

    Trois-Rivières, Quebec, G8T 7A1, Canada

  • Investigational Site Number : 1240003

    Québec, G1V 4W2, Canada

  • Investigational Site Number : 1240005

    Québec, G1V 4G5, Canada

  • Investigational Site Number : 1240007

    Kingston, Ontario, K7L 2V7, Canada

  • Investigational Site Number : 1240010

    Hamilton, Ontario, L8L 2X2, Canada

  • Investigational Site Number : 1240012

    Montreal, Quebec, H4A 3J1, Canada

  • Investigational Site Number : 1240013

    Vancouver, British Columbia, V6Z 1Y6, Canada

  • Investigational Site Number : 1240016

    London, Ontario, N6A 4V2, Canada

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 8207257, Chile

  • Investigational Site Number : 1560001

    Beijing, 100730, China

  • Investigational Site Number : 1560005

    Changchun, 130021, China

  • Investigational Site Number : 1560006

    Shanghai, 200065, China

  • Investigational Site Number : 1560008

    Yantai, 264000, China

  • Investigational Site Number : 1560010

    Chongqing, 400016, China

  • Investigational Site Number : 1560013

    Changsha, 410013, China

  • Investigational Site Number : 3480001

    Pécs, 7621, Hungary

  • Investigational Site Number : 3480004

    Budapest, 1115, Hungary

  • Investigational Site Number : 4100002

    Seoul, Seoul-teukbyeolsi, 135-710, South Korea

  • Investigational Site Number : 4100003

    Seoul, Seoul-teukbyeolsi, 07061, South Korea

  • Investigational Site Number : 6200001

    Guimarães, 4810-061, Portugal

  • Investigational Site Number : 6200002

    Aveiro, 3810-501, Portugal

  • Investigational Site Number : 6200003

    Matosinhos Municipality, 4464-513, Portugal

  • Investigational Site Number : 6430001

    Stavropol, 355020, Russia

  • Investigational Site Number : 6430002

    Saint Petersburg, 197022, Russia

  • Investigational Site Number : 6430003

    Saint Petersburg, 197022, Russia

  • Investigational Site Number : 6430005

    Moscow, 121359, Russia

  • Investigational Site Number : 7240001

    Barcelona, Barcelona [Barcelona], 08036, Spain

  • Investigational Site Number : 7240002

    Seville, Andalusia, 41009, Spain

  • Investigational Site Number : 7240004

    Jerez de la Frontera, Cádiz, 11407, Spain

  • Investigational Site Number : 7240005

    Madrid / Madrid, Madrid, Comunidad de, 28040, Spain

  • Investigational Site Number : 7240007

    Santander, Cantabria, 39008, Spain

  • Investigational Site Number : 7240008

    Pamplona, Navarre, 31008, Spain

  • Investigational Site Number : 7240009

    Madrid, Madrid, Comunidad de, 28027, Spain

  • Investigational Site Number : 7240010

    Madrid, 28034, Spain

  • Investigational Site Number : 7520001

    Stockholm, 171 76, Sweden

  • Investigational Site Number : 8040001

    Ivano-Frankivsk, 76018, Ukraine

  • Investigational Site Number : 8040002

    Kyiv, 03680, Ukraine

  • Investigational Site Number : 8040004

    Kharkiv, 61166, Ukraine

  • Investigational Site Number : 8040005

    Dnipro, 49006, Ukraine

  • Investigational Site Number : 8040007

    Kyiv, 04050, Ukraine

  • Investigational Site Number : 8040008

    Kyiv, 01033, Ukraine

  • Nebraska Medical Research Institute Site Number : 8400007

    Papillion, Nebraska, 68046, United States

  • Optimed Research, LTD Site Number : 8400017

    Columbus, Ohio, 43235, United States

  • Pharmaceutical Research & Consulting, Inc. Site Number : 8400006

    Dallas, Texas, 75231, United States

  • Sacramento Ear, Nose & Throat Site Number : 8400010

    Roseville, California, 95661, United States

  • University of Missouri Health System Site Number : 8400016

    Columbia, Missouri, 65212, United States

  • Vital Prospects Clinical Research Institute, P.C. Site Number : 8400004

    Tulsa, Oklahoma, 74136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.